Glenmark Pharmaceuticals Claimed Company
Developer of pharmaceutical molecular entities, formulations and active pharmaceutical ingredients created to deal with issues of child health care. The company's pharmaceutical molecular entities, formulations and active pharmaceutical ingredients offer generic drugs manufactured in the US, Argentina, Czech Republic and India, enabling patients to be treated for conditions such as inflammation, pain and oncology. read more
HR or Marketing? Claim Your Free Employer Account
John Kauh ā Executive Director Clinical Sciences - Oncology at Glenmark Pharmaceuticals
Executive Bio
John Kauh serves as the Executive Director Clinical Sciences - Oncology of Glenmark Pharmaceuticals. John started at Glenmark Pharmaceuticals in May of 2017. John currently resides in the Greater New York City Area.
Executive Team Culture Ratings from Glenmark Pharmaceuticals Employees
TOP
5%
Glenmark Pharmaceuticals' Executive Team scores in the Top 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Glenmark PharmaceuticalsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Glenmark PharmaceuticalsGlenmark Pharmaceuticals' Executive Team at a Glance
Based on 3 ratings, Glenmark Pharmaceuticals' employees are very satisfied with their Executive Team and give them an āA+ā or 80/100.
Glenmark Pharmaceuticals' Executive Team ranks in the Top 5% of other companies on Comparably that also have 10,000+ Employees.
×